6[6]Schneider LS.Increased mortality associated with cholinesterase inhibitors in VCI.International Alzheimer Association Conference.Madrid,Spain.June 2006.
7[7]Moretti R,Torre P,Antonello RM,et al.Rivastigmine in subcortical vascular dementia:a randomized,controlled,open 12-month study in 208 patients[J].Am J Alzheimers Dis Other Demen,2003,18:265-272.
10[10]Rainer M,MUCke HA,Kruger-Rainer C,et al.Cognitive relapse after discontinuation of drug therapy in Alzheimer's disease:cholinesterase inhibitors versus nootropics[J].J Neural Transm,2001,108:1327.
3Jin YP,Di Legge S,Ostbye T. The reciprocal risks of stroke and cognitive impairment in an elderly population[J].Alzheimers Dement,2006,(03):171-178.
4Barba R,Marti nez-Espinosa S,Rodríguez-García E. Poststroke dementia:clinical features and risk factors[J].Stroke,2000.1494-1501.
5Rockwood K,Wentzel C,Hachinski V. Prevalence and outeomes of vascular cognitive impairment.Vascular Cognitive Impairment investigators of the Canadian Study of Health and Aging[J].Neurology,2000.447-451.
6Ingles JL,Wentzel C,Fisk JD. Neuropsychological predictors of incident dementia in patients with vaseular cognitive impairment,without dementia[J].Stroke,2002,(08):1999-2002.
7Mieike MM,Zandi PP,Sjogren M. High total cholesterol levels in late Life associated with a reduced risk of dementia[J].Neurology,2005,(10):1689-1695.
8K(o)lsch H,Heun R,Kerksiek A. Altered levels of plasma 24S-and 27-hydroxycholesterol in demented patients[J].Neuroscience Letters,2004,(03):303-308.
9Eikelboom JW,Hankey G J,Anand SS. Association between high homocysteine and ischemic stroke due to large-and small-artery disease but not other etiologic subtypes of ischemic stroke[J].Stroke,2000,(05):1069-1075.
